CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?
about
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
CD38, BCL-2, PD-1, and PD-1L e ...... for novel targeted therapies?
@en
CD38, BCL-2, PD-1, and PD-1L e ...... for novel targeted therapies?
@nl
type
label
CD38, BCL-2, PD-1, and PD-1L e ...... for novel targeted therapies?
@en
CD38, BCL-2, PD-1, and PD-1L e ...... for novel targeted therapies?
@nl
prefLabel
CD38, BCL-2, PD-1, and PD-1L e ...... for novel targeted therapies?
@en
CD38, BCL-2, PD-1, and PD-1L e ...... for novel targeted therapies?
@nl
P2093
P2860
P50
P356
P1476
CD38, BCL-2, PD-1, and PD-1L e ...... for novel targeted therapies?
@en
P2093
Angelica Calleri
Elena Sabattini
Pier Luigi Zinzani
Renato Fanin
Stefano A Pileri
Stefano Volpetti
P2860
P356
10.1002/AJH.24571
P577
2016-11-10T00:00:00Z